Literature DB >> 35670854

Low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion: unique morphology akin to subsets of sinonasal low-grade non-intestinal-type adenocarcinoma.

Satsuki Kishikawa1, Takuo Hayashi2, Junzo Shimizu3, Bungo Fuwa4, Akitaka Nonomura4, Tsuyoshi Saito1, Yasushi Yatabe5, Takashi Yao1.   

Abstract

The prevalence of NTRK fusions in non-small cell carcinoma (NSCLC) is only approximately 0.2%, most of which harbor NTRK1 fusions. NSCLCs with NTRK3 fusions are extremely rare. Herein, we report a case of low-grade tracheal adenocarcinoma in a 64-year-old woman. Histologically, areas of complicated tubule-papillary or cribriform patterns constituted a major component of the tumor and comprised cuboidal to columnar epithelial tumor cells with pale eosinophilic cytoplasm and cytoplasmic mucin, similar to subsets of sinonasal low-grade non-intestinal-type adenocarcinomas. Immunohistochemically, the tumor was positive for MUC5AC and MUC4 and showed nuclear expression of the pan-Trk antibody. ETV6::NTRK3 was identified by reverse transcription-polymerase chain reaction using formalin-fixed paraffin-embedded tissues. To the best of our knowledge, this is the first case of low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion. Our case illustrates that low-grade adenocarcinomas with ETV6::NTRK3 fusion may exist throughout the respiratory tract.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  ETV6::NTRK3 fusion; Tracheal adenocarcinoma; Tracheal tumor

Year:  2022        PMID: 35670854     DOI: 10.1007/s00428-022-03353-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  Expression of ETV6-NTRK in classical, cellular and mixed subtypes of congenital mesoblastic nephroma.

Authors:  J Anderson; S Gibson; N J Sebire
Journal:  Histopathology       Date:  2006-05       Impact factor: 5.087

2.  Primary Mammary-Analogue Secretory Carcinoma of the Lung: A Rare Entity With an Unusual Location.

Authors:  Josean Ramos; Waqas Mahmud; Fernando Alekos Ocampo; Gillian Alex; Paolo Gattuso
Journal:  Int J Surg Pathol       Date:  2020-04-12       Impact factor: 1.271

Review 3.  Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression.

Authors:  Pooja Vasudev; Kazuya Onuma
Journal:  Arch Pathol Lab Med       Date:  2011-12       Impact factor: 5.534

4.  ETV6-NTRK3 translocation-associated low-grade mucinous bronchial adenocarcinoma: A novel bronchial salivary gland-type non-small cell lung cancer subtype.

Authors:  J H von der Thüsen; D W Dumoulin; A P W M Maat; J Wolf; A H Sadeghi; J G J V Aerts; R Cornelissen
Journal:  Lung Cancer       Date:  2021-04-16       Impact factor: 5.705

5.  Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors.

Authors:  J M Bourgeois; S R Knezevich; J A Mathers; P H Sorensen
Journal:  Am J Surg Pathol       Date:  2000-07       Impact factor: 6.394

6.  Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.

Authors:  Alena Skálová; Tomas Vanecek; Radek Sima; Jan Laco; Ilan Weinreb; Bayardo Perez-Ordonez; Ivo Starek; Marie Geierova; Roderrick H W Simpson; Fabricio Passador-Santos; Ales Ryska; Ilmo Leivo; Zdenek Kinkor; Michal Michal
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

Review 7.  The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.

Authors:  Andrew G Nicholson; Ming S Tsao; Mary Beth Beasley; Alain C Borczuk; Elisabeth Brambilla; Wendy A Cooper; Sanja Dacic; Deepali Jain; Keith M Kerr; Sylvie Lantuejoul; Masayuki Noguchi; Mauro Papotti; Natasha Rekhtman; Giorgio Scagliotti; Paul van Schil; Lynette Sholl; Yasushi Yatabe; Akihiko Yoshida; William D Travis
Journal:  J Thorac Oncol       Date:  2021-11-20       Impact factor: 20.121

8.  NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.

Authors:  James P Solomon; Irina Linkov; Andrea Rosado; Kerry Mullaney; Ezra Y Rosen; Denise Frosina; Achim A Jungbluth; Ahmet Zehir; Ryma Benayed; Alexander Drilon; David M Hyman; Marc Ladanyi; Anthony N Sireci; Jaclyn F Hechtman
Journal:  Mod Pathol       Date:  2019-08-02       Impact factor: 7.842

9.  Primary mammary analogue secretory carcinoma of the lung: a case report.

Authors:  Tao Huang; Jonathan B McHugh; Gerald J Berry; Jeffrey L Myers
Journal:  Hum Pathol       Date:  2017-11-02       Impact factor: 3.466

10.  Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors.

Authors:  Taisei Kurihara; Yoshiyuki Suehara; Keisuke Akaike; Takuo Hayashi; Shinji Kohsaka; Toshihide Ueno; Nobuhiko Hasegawa; Tatsuya Takagi; Keita Sasa; Taketo Okubo; Youngji Kim; Hiroyuki Mano; Takashi Yao; Kazuo Kaneko; Tsuyoshi Saito
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.